Nektar Skin Cancer Combo Spurs More Patient Remissions Over Time

(Bloomberg) -- A treatment plan including Nektar Therapeutics’ experimental therapy helped more patients with advanced skin cancer beat back their disease after more than a year of follow up.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.